KV Securities Plaintiffs Fight Denial Of Bid To Amend

Law360, New York (November 4, 2010, 6:34 PM EDT) -- The plaintiffs in a securities lawsuit accusing KV Pharmaceutical Co. of making misstatements and omissions amid widespread drug recalls have appealed a judge's decision not to allow them to file an amended complaint.

Attorneys for the plaintiffs notified the U.S. District Court for the Eastern District of Missouri on Monday that they are appealing the ruling to the U.S. Court of Appeals for the Eighth Circuit. The plaintiffs have already appealed a February ruling that dismissed their complaint.

The suit claimed that KV concealed information regarding...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.